Patents Assigned to LAPKO INC.
  • CCL2 inhibitors
    Patent number: 11858876
    Abstract: Compounds, pharmaceutically acceptable salts, and pharmaceutical compositions thereof are disclosed that are useful for inhibition of the biological activity of CCL2, as well as methods of treatment for diseases involving the biological activity of CCL2.
    Type: Grant
    Filed: September 24, 2021
    Date of Patent: January 2, 2024
    Assignee: LAPKO INC.
    Inventors: Bruce Kovacs, Kamron Shahbahrami, George Nicola
  • CCL2 inhibitors
    Patent number: 11130729
    Abstract: Compounds, pharmaceutically acceptable salts, and pharmaceutical compositions thereof are disclosed that are useful for inhibition of the biological activity of CCL2, as well as methods of treatment for diseases involving the biological activity of CCL2.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: September 28, 2021
    Assignee: LAPKO INC.
    Inventors: Bruce Kovacs, Kamron Shahbahrami, George Nicola